Know Labs News

Know Labs Joins the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University

The Company's experience in developing novel, next generation medical diagnostic technology aligns with the Wyss Diagnostics Accelerator's mission of delivering disruptive innovation to address unmet

BusinesswireJun 5 09:00 ET

Know Labs Price Target Maintained With a $1.00/Share by Benchmark

Know Labs Price Target Maintained With a $1.00/Share by Benchmark

Dow JonesMay 29 09:17 ET

Express News | Benchmark Reiterates Speculative Buy on Know Labs, Maintains $1 Price Target

BenzingaMay 29 09:07 ET

Express News | Know Labs Appoints Chris Somogyi as President, International

ReutersMay 16 09:00 ET

Know Labs Inc (KNW) Q2 2024 Earnings Call Transcript Highlights: Strategic Developments Amid ...

Yahoo FinanceMay 16 03:07 ET

Earnings Call Summary | Know Labs(KNW.US) Q2 2024 Earnings Conference

The following is a summary of the Know Labs, Inc. (KNW) Q2 2024 Earnings Call Transcript:Financial Performance:Know Labs reported an operating loss of $4.73 million for Q2 2024, a decrease of 1.7% fro

moomoo AIMay 16 00:12 ET · Conference Call

Know Labs | 10-Q: Quarterly report

SEC announcementMay 15 16:27 ET · Announcements

Express News | Know Labs Q2 2024 GAAP EPS $(0.07) Misses $(0.05) Estimate

BenzingaMay 15 16:26 ET

Know Labs 2Q Loss/Shr 7c >KNW

Know Labs 2Q Loss/Shr 7c >KNW

Dow JonesMay 15 16:20 ET

Express News | Know Labs, Inc. Reports Second Quarter FY 2024 Results

ReutersMay 15 16:15 ET

Know Labs to Present Clinical Research at the 2024 American Association of Clinical Endocrinology Annual Meeting

The Company's oral abstract presentation features results from its clinical study that demonstrate the accuracy and medical application of its proprietary sensor. Know Labs, Inc. (NYSE:KNW), an emerging developer of

BusinesswireMay 9 09:00 ET

Press Release: Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024

Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024 SEATTLE--(BUSINESS WIRE)--May 08, 2024-- Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-

Dow JonesMay 8 09:04 ET

Know Labs, Inc. to Host Review of Second Quarter Fiscal Year 2024 Results on May 15, 2024

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it will host a webcast to review business updates a

BusinesswireMay 8 09:00 ET

Know Labs Price Target Announced at $1.00/Share by Benchmark

Know Labs Price Target Announced at $1.00/Share by Benchmark

Dow JonesApr 8 08:14 ET

Know Labs Initiated at Speculative Buy by Benchmark

Know Labs Initiated at Speculative Buy by Benchmark

Dow JonesApr 8 08:14 ET

Express News | Benchmark Initiates Coverage On Know Labs With Speculative Buy Rating, Announces Price Target of $1

Moomoo 24/7Apr 8 08:03 ET

Know Labs Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/08/2024 56.01% Benchmark → $1 Initiates Coverage On → Speculative Buy

BenzingaApr 8 08:02 ET

Know Labs to Present Clinical Research at the 2024 American Physiology Summit

The Company demonstrates significant progress since presenting at last year's Summit. Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been

BusinesswireApr 5 09:00 ET

Know Labs Reports Promising Results From Clinical Study

TipRanksMar 6 16:25 ET

Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study

Know Labs' first study including participants with diabetes and venous blood as a comparative reference demonstrates its proprietary sensor's accuracy and medical application.SEATTLE--(BUSINESS WIRE)-

BusinesswireMar 6 09:00 ET